Stock listing
VSTM Stock Price, News, Filings & Events — Verastem, Inc.
Selected listing: VSTM · NASDAQ · USD · US
This page tracks Verastem, Inc.'s VSTM:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VSTM:NASDAQ. VSTM:NASDAQ is the stock-level entry point for investors researching Verastem, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Verastem, Inc. is a public company traded under the ticker VSTM in the American market. The company has a market capitalization of approximately $531.6 million. Verastem focuses on developing therapies for cancer treatment, aiming to improve patient outcomes.
- Ticker
- VSTM:NASDAQ
- Asset type
- Stock
- Market cap
- $662.9M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Verastem, Inc. VSTM:NASDAQ stock context
This page tracks Verastem, Inc.'s VSTM:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VSTM:NASDAQ. VSTM:NASDAQ is the stock-level entry point for investors researching Verastem, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Verastem, Inc. is a public company traded under the ticker VSTM in the American market. The company has a market capitalization of approximately $531.6 million. Verastem focuses on developing therapies for cancer treatment, aiming to improve patient outcomes.
Latest news from Verastem, Inc.
Verastem Oncology to Unveil New Clinical Data Highlighting the Best-in-Class Potential of VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor, ...
September 8, 2026
Verastem Oncology to Participate in Upcoming September Investor Conferences
September 2, 2026
Verastem Oncology Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates
August 6, 2026
Verastem Oncology Doses First Patient in TARGET-D 203 Phase 2 Registration-Directed Trial of VS-7375 Oral KRAS G12D (ON/OFF) Inhibitor fo...
July 28, 2026
Verastem Oncology to Report Second Quarter 2026 Financial Results on August 6, 2026
July 23, 2026
Verastem, Inc. earnings calls
Verastem, Inc. (VSTM) Q2 2026 Earnings Call
August 6, 2026 · Replay with transcript and chapters
Verastem, Inc. (VSTM) Q1 2026 Earnings Call
May 7, 2026 · Replay with transcript and chapters
Verastem, Inc. (VSTM) Q4 2025 Earnings Call
March 4, 2026 · Replay with transcript and chapters
Verastem, Inc. (VSTM) Q3 2025 Earnings Call
November 4, 2025 · Replay with transcript and chapters
Verastem, Inc. (VSTM) Q2 2025 Earnings Call
August 7, 2025 · Replay with transcript and chapters
Research Verastem, Inc.
Verastem, Inc. investor report
Review AI stock analysis and investor report context for VSTM:NASDAQ.
Verastem, Inc. company profile
View the public company page for Verastem, Inc. on 6ix.
Verastem, Inc. news
Read company news and market updates connected to Verastem, Inc..
Verastem, Inc. investor events
Find investor webinars, events, and replay context for Verastem, Inc..
Alternate listings
A3EHM3:LSX
DE · EUR
Alternate listing for Verastem, Inc.; the primary context on this page is VSTM:NASDAQ.
A3EHM3:LS
DE · EUR
Alternate listing for Verastem, Inc.; the primary context on this page is VSTM:NASDAQ.
2VSA:GETTEX
DE · EUR
Alternate listing for Verastem, Inc.; the primary context on this page is VSTM:NASDAQ.
VSTM:BOATS
US · USD
Alternate listing for Verastem, Inc.; the primary context on this page is VSTM:NASDAQ.
0LOV:LSE
GB · USD
Alternate listing for Verastem, Inc.; the primary context on this page is VSTM:NASDAQ.
2VSA:DUS
DE · EUR
Alternate listing for Verastem, Inc.; the primary context on this page is VSTM:NASDAQ.
2VSA:FWB
DE · EUR
Alternate listing for Verastem, Inc.; the primary context on this page is VSTM:NASDAQ.
2VSA:HAM
DE · EUR
Alternate listing for Verastem, Inc.; the primary context on this page is VSTM:NASDAQ.
2VSA:MUN
DE · EUR
Alternate listing for Verastem, Inc.; the primary context on this page is VSTM:NASDAQ.
2VSA:SWB
DE · EUR
Alternate listing for Verastem, Inc.; the primary context on this page is VSTM:NASDAQ.
2VSA:TRADEGATE
DE · EUR
Alternate listing for Verastem, Inc.; the primary context on this page is VSTM:NASDAQ.